Anthropometry (2)
- HEIGHT - Height measured at enrollment (phv00530744.v1.p1)
- WEIGHT - Weight measured at enrollment (phv00530745.v1.p1)
Biomarkers (1)
- HRATE - Heart rate at enrollment (phv00530749.v1.p1)
Demographics (4)
- AGE - Subject age at enrollment (phv00530742.v1.p1)
- COLLECTION_AGE - Age at sample collection (phv00530778.v1.p1)
- SEX - Biological sex (phv00530738.v1.p1)
- TEMP - Body Temperature at enrollment (phv00530748.v1.p1)
Disease Events (13)
- BREATH - Shortness of breath/Dyspnea at enrollment (phv00530753.v1.p1)
- CONFU - Altered consciousness at enrollment (phv00530759.v1.p1)
- COUGH - Cough at enrollment (phv00530751.v1.p1)
- DIARRHEA - Diarrhea at enrollment (phv00530761.v1.p1)
- FATIGUE - Fatigue/Malaise at enrollment (phv00530757.v1.p1)
- FEV - Fever at enrollment (phv00530750.v1.p1)
- HEADACHE - Headache at enrollment (phv00530758.v1.p1)
- MUSCLE - Muscle aches/Myalgia at enrollment (phv00530756.v1.p1)
- NIH_SEVEREITY - COVID-19 severity according to NIH guideline (phv00530747.v1.p1)
- NIH_SEVEREITY - COVID-19 Severity according to the NIH guideline (phv00530780.v1.p1)
- RHINO - Runny nose/Rhinorrhea at enrollment (phv00530755.v1.p1)
- SPUTUM - Sputum production at enrollment (phv00530752.v1.p1)
- VOMIT - Vomiting/Nausea at enrollment (phv00530760.v1.p1)
Medications (6)
- AVIRUS_1 - Antiviral treatment history at enrollment (phv00530767.v1.p1)
- AVIRUS_2 - Antiviral treatment history after enrollment (phv00530770.v1.p1)
- AVIRUSO_1 - Other antiviral treatment administration history (phv00530769.v1.p1)
- AVIRUSO_2 - Other antiviral treatment administration after enrollment (phv00530772.v1.p1)
- AVIRUSR_1 - Remdesivir administration history (phv00530768.v1.p1)
- AVIRUSR_2 - Remdesivir administration after enrollment (phv00530771.v1.p1)
Race and Ethnicity (1)
- RACE - Self-reported race (phv00530743.v1.p1)
Other (20)
- AFFECTION_STATUS - COVID-19 infection status (phv00530746.v1.p1)
- ANALYTE_TYPE - Analyte Type (phv00530776.v1.p1)
- ANTIVIRAL - Antiviral treatment status (phv00530781.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00530775.v1.p1)
- COLLECTION_DATE - Days after sample collection (Day 0) (phv00530779.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00530737.v1.p1)
- ER - Status at the end of monitoring (phv00530773.v1.p1)
- IS_COVID - COVID-19 Infection Status (phv00530777.v1.p1)
- SAMPLE_ID - Sample ID (phv00530774.v1.p1)
- SAMPLE_ID - Sample ID (phv00530740.v1.p1)
- SUBJECT_ID - Assigned Subject ID for each individual (phv00530741.v1.p1)
- SUBJECT_ID - Subject ID (phv00530736.v1.p1)
- SUBJECT_ID - Subject ID (phv00530739.v1.p1)
- THROAT - Sore throat at enrollment (phv00530754.v1.p1)
- VACCINATION - Vaccination status (phv00530782.v1.p1)
- VACN - Number of Vaccine Dose (phv00530762.v1.p1)
- VACN1 - Type of 1st dose vaccine administered (phv00530763.v1.p1)
- VACN2 - Type of 2nd dose vaccine administered (phv00530764.v1.p1)
- VACN3 - Type of 3rd dose vaccine administered (phv00530765.v1.p1)
- VACN4 - Type of 4th dose vaccine administered (phv00530766.v1.p1)